Three strains of Pseudomonas aeruginosa resistant to gentamicin obtained as representative gentamicin-resistant clinical isolates from the University of Alberta Hospital (UAH) in Edmonton, Canada were characterized to determine their mechanism of resistance. All strains showed wide aminoglycoside resistance (tobramycin, sisomicin, amikacin, streptomycin, kanamycin, SCH 20569) but contained no evidence of gentamicin-acetylating, adenylylating or phosphorylating activity. Gentamicin inhibited amino-acid incorporation in cell-free systems equally well with either ribosomes or soluble cell fractions obtained from either resistant or sensitive strains. Plasmid DNA was detected in two strains but resistance could not be transferred by conjugation to either P. aeruginosa or Escherichia coli recipients. The resistant strains showed a marked reduction in energy-dependent accumulation of gentamicin compared to a sensitive strain. These strains which are common at UAH are most likely resistant due to a failure of gentamicin to be transported across the cytoplasmic membrane to ribosomal sites until relatively high external gentamicin concentrations.
Resistance of certain strains of Pseudomonas aeruginosa to gentamicin has been shown to be due to enzymatic adenylylation or acetylation of gentamicin (for review see (1) ). Most of the strains possessing these enzymes that we have examined were able to transfer increased gentamicin resistance and the enzymatic activity by conjugation to recipient strains of P. aeruginosa. The nature of these strains and their R-factors have been previously detailed. 5) In carrying out surveillance of clinical-isolates of P. aeruginosa we have found at the University of Alberta Hospital in Edmonton, Canada a large number of strains resistant to gentamicin which do not contain detectable enzymatic gentamicin modification. We present in this study a characterization of these strains and an examination of their significance in mediating clinically important gentamicin resistance. Material and Methods
Bacterial strains. The source and characteristics of strains are given in Table  1 Table   6 for amino-acid concentrations). Whole cell incorporation of 3H-gentamicin. Gentamicin uptake was measured as described4) using gentamicin tritiated by catalytic exchange (Amersham-Searle) and subsequently repurified Concentrations of aminoglycosides (ug/ml) valine. *** ND: not done . compared to that using components from a known sensitive strain. * dpm-disintegrations per minute , counting efficiency-60 %. ** Each assay (0 .7 ml) contains 0.5 ml of deoxyribonuclease-treated extract from alumina ground cells as a source of mRNA, tRNA, ribosomes and other non-ribosomal components of protein synthesis; 0.7 nmoles of all amino acids (12 of the 20 amino acids were labelled with 14C each with a specific activity of 50 uCi/,umole; Schwarz/Mann); ATP, ATP-generating system, and other reagents were added as described.
Magnesium concentration was 9 mmolar. Concentrations of gentamicin were 10 ug/ml and streptomycin 20 ug/ml. Sample size was 50 ul and incubation was at 34°C for 30 min. Control tubes (zero time) dpm were 100150 and have been subtracted from the values given above. the most likely explanation of resistance is a reduction in the amount of the aminoglycosides entering the bacterial cell. Such could be due to a permeability barrier provided by the cell wall. The cell wall has been repeatedly shown to influence antibiotic penetration including aminoglycoside penetration. Cell wall active reagents do enhance gentamicin accumulation but to a similar extent in both resistant and sensitive strains. Thus although the cell wall contributes to gentamicin resistance in general it does not seem the explanation of the differential resistance of strains like 8803, 1136 and 13934. We have recently shown that gentamicin cellular entry is an active process composed of at least three kinetic components.4) The first or ionic binding phase is similar in each of the resistant strains and sensitive strain 280. However second phase accumulation does not begin in strain 8803 until a much higher concentration than that necessary for second phase accumulation in strain 280. Thus the major explanation for resistance seems to be a requirement for an increased gentamicin concentration to initiate second phase transport. This transport phase is dependent on aerobically generated energy and is necessary for cell death.4) The actual mode of transport is unknown but we propose that the transport mechanism for gentamicin has reduced affinity for or access to gentamicin in the resistant strains. Thus gentamicin is not transported to the ribosomal site until much higher concentrations of gentamicin are present in the medium. This interpretation is supported by the observation that mutants with reduced cytochrome content and thus reduced aerobically generated energy show increased resistance to aminoglycosides. It is important to emphasize that strains 8803, 1136 and 13934 do not appear to be defective in cytochromes by visual spectrometry and have normal growth patterns. Also they were isolated from clinical circumstances (burns and pneumonia) and thus are capable of contributing to a pathological state. However, strain 8803 in particular may have some reduction in virulence. In spite of high gentamicin resistance and delayed healing of a burn associated with heavy colonization with 8803 in a 8-year-old boy the child did not suffer from septicemia and his skin graft was eventually successful.
